Stay updated with breaking news from Simplify Disc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The Artificial Disc Replacement Market is anticipated to grow significantly, reaching approximately USD 2,032.6 million by 2033, up from USD 660.3 million in 2023. This growth is projected at a Compound Annual Growth Rate (CAGR) of 11.9% from 2024 to 2033. The market is driven by several key factors, including the i...
Operator: Good day, ladies and gentlemen, and welcome to the NuVasive Fourth Quarter and Full Year 2022 Earnings Conference Call. I would now like to introduce your host for today's call, Ms.
/PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive,...
NuVasive today announced data from an FDA investigational device exemption study supporting its Simplify cervical disc.
Share this article Share this article WASHINGTON, May 12, 2021 /PRNewswire/ -- MCRA, LLC, the leading privately held medical device and biologics advisory firm and Clinical Research Organization (CRO) integrating U.S. and International Regulatory, Clinical Research, Reimbursement, Healthcare Compliance, Quality Assurance, and Medical Device Cybersecurity, is pleased to announce its role in the successful management and execution of Simplify Medical's two clinical studies and approvals by the U.S. Food and Drug Administration (FDA) for the Simplify Cervical Artificial Disc (Simplify Disc) to ...